CIK 0001679628 · <br>Emerging growth company
JUPITER NEUROSCIENCES, INC.
Sign in to watch- Ticker
- JUNS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474828381
- Phone
- (561) 406-6154
- Business address
- 1001 NORTH US HWY 1, SUITE 504, JUPITER, FL, 33477
- Former names
- Jupiter Orphan Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-02 | Rosen Alexander Gustaf Erik Chief Administrative Officer | Option exercise · Restricted Stock Units | −164,554 | 0 | ||
| 2025-06-02 | Rosen Alexander Gustaf Erik Chief Administrative Officer | Option exercise · Restricted Stock Award | −96,608 | 0 | ||
| 2025-06-02 | Hayward Marshall A. Chief Scientific Officer | Option exercise | +389,793 | 2,370,675 | ||
| 2025-06-02 | Hayward Marshall A. Chief Scientific Officer | Option exercise | +399,402 | 2,770,077 | ||
| 2025-06-02 | Hayward Marshall A. Chief Scientific Officer | Option exercise · Restricted Stock Units | −389,793 | 0 | ||
| 2025-06-02 | Hayward Marshall A. Chief Scientific Officer | Option exercise · Restricted Stock Award | −399,402 | 0 | ||
| 2025-06-02 | Hemmerly Nicholas H. Director | Option exercise | +95,550 | 95,550 | ||
| 2025-06-02 | Hemmerly Nicholas H. Director | Option exercise · Restricted Stock Units | −95,550 | 0 | ||
| 2025-06-02 | Weis Holger Director | Option exercise | +85,800 | 96,581 | ||
| 2025-06-02 | Weis Holger Director | Option exercise · Restricted Stock Units | −85,800 | 0 | ||
| 2025-06-02 | Elmasri Saleem CFO and Secretary | Option exercise | +66,293 | 66,239 | ||
| 2025-06-02 | Silva Alison D. Pres + Chief Business Officer | Option exercise | +110,227 | 110,227 | ||
| 2025-06-02 | ROSEN CHRISTER CEO and Chairman | Option exercise | +497,396 | 10,591,406 | ||
| 2025-06-02 | ROSEN CHRISTER CEO and Chairman | Option exercise | +476,070 | 11,067,476 | ||
| 2025-01-22 | Weis Holger Director | Option exercise | +10,781 | 10,781 | ||
| 2025-01-22 | Weis Holger Director | Option exercise · Convertible Notes | −10,781 | $2.80 | $30K | 10,781 |
| 2025-01-22 | Brady Allison W Director | Option exercise | +21,750 | 21,750 | ||
| 2025-01-22 | Brady Allison W Director | Option exercise · Convertible Notes | −21,750 | $2.80 | $61K | 21,750 |
Page 3 of 3 · 58 trades